(MENAFN- EIN Presswire)
Acne treatment Market
Rising Awareness, Innovation, and Personalized Solutions Fueling Global Acne Treatment market Growth
AUSTIN, TX, UNITED STATES, November 11, 2024 /EINPresswire / -- The Acne Treatment Market size was estimated at USD 10.54 billion in 2023 and is expected to reach USD 16.65 billion by 2032 at a CAGR of 5.25% during the forecast period of 2024-2032.
The acne treatment market is in considerable growth driven by increasing demand, awareness, and ongoing innovation into different treatment modalities. The anti-acne market in the United States saw significant growth in 2023, with Hero Cosmetics spearheading the event by taking home about USD 214 million in sales. Neutrogena and Panoxyl also listed sales which proved them to be quite in demand.
Get a Sample Copy of the Report @
Increasing Demand for AI-Powered Personalized Skincare Solutions
Emerging technologies, especially artificial intelligence (AI), are revolutionizing the acne treatment field by facilitating customized skincare approaches. In South Korea, the beauty technology sector, estimated to be worth around USD 0.53 billion in 2024, is projected to expand at a CAGR of 5.23% until 2032. AI-powered acne therapies present cutting-edge remedies customized to unique skin requirements, utilizing smartphone cameras and AI technologies to identify and track acne, delivering tailored treatment suggestions.
This movement toward personalization aligns with consumers' increasing demands for accurate and efficient skincare remedies. AI not only provides personalized recommendations but also improves the efficiency of treatment plans by adjusting to each individual's specific skin profile. This increase in technology-focused, patient-oriented skincare solutions is creating opportunities for ongoing expansion and advancement in the acne treatment sector.
Market Analysis: A Dynamic Landscape of Innovation and Demand
Due to technological progress and growing consumer interest, the acne treatment market is becoming more vibrant. Laser and light therapies are expanding treatment choices, as there is a rising demand for tailored solutions that cater to individual patient requirements. Devices driven by AI that assess skin conditions and suggest customized treatments are anticipated to greatly influence market expansion. As buyers look for innovative, tailored skincare solutions, the market is set for consistent growth, fueled by developing treatment techniques and a forward-thinking approach to skin wellness.
Key Players:
➢Differin (Acne-Clearing Body Scrub, Differin Gel)
➢Neutrogena (Neutrogena Oil-Free Acne Wash Facial Cleanser, Neutrogena Oil-Free Acne Wash)
➢Clearasil (Clearasil Ultra Rapid Action Treatment, Clearasil Stay Clear Biactol Daily Gel)
➢CeraVe (CeraVe Resurfacing Retinol Serum, CeraVe Acne Control Gel)
➢PanOxyl (PanOxyl Acne Creamy Wash, PanOxyl Overnight Spot Patches)
➢Hero Cosmetics (Pimple Correct, Micropoint for Blemishes)
➢StarFace (Blackstar, acne patch stickers)
➢La Rochey Poshay (Effaclar Duo Acne Spot Treatment, Effaclar Salicylic Acid Acne Treatment Serum)
➢ABBVIE (SkinMedica Pro-Infusion Serums, DiamondGlow)
➢Botanix Pharmaceuticals (BTX1503, BTX1702)
➢Bausch Health Companies Inc. (Clindamycin Phosphate Gel, AcneFree Oil-Free Acne Cleanser)
➢GlaxoSmithKline Plc. (Benzac AC (Benzoyl Peroxide), PanOxyl (Benzoyl Peroxide))
➢Bayer AG (Bepanthen Ointment, Clearasil)
Segment Analysis: Dominance of Topical Treatments and Growing Demand for Severe Acne Solutions
By Route of Administration:
Topical drugs dominated the acne treatment market, accounting for approximately 59% of revenue in 2023. This segment's dominance is attributed to the accessibility and effectiveness of topical solutions, particularly those containing retinoids and antibiotics. Patients often favor topical treatments for their ease of use and efficacy in managing various forms of acne. The oral drug segment is projected to grow at a CAGR of 5.76%, driven by increased diagnosis rates and greater awareness of the benefits of oral medications for severe acne cases.
By Acne Type:
In 2023, treatments for moderate to severe acne accounted for approximately 53.08% of total revenues, highlighting the necessity for targeted solutions to mitigate the substantial effects of severe acne on quality of life. The emotional and psychological impact of severe acne has increased the need for more robust and effective treatments. With increasing recognition of the significance of thorough acne management, the market for treatments targeting moderate to severe acne is projected to grow even more.
Buy Full Research Report on Acne Treatment Market 2024-2032 @
Regional Insights: North America Leads While Asia Pacific Shows Promising Growth
In 2023, North America dominated the worldwide acne treatment market, holding a 45% share of the revenue. The strong demand for skincare and personal care, along with a varied population in need of effective acne treatments, has fueled market expansion in this area. In October 2023, a significant advancement in North America's acne treatment arena occurred when the U.S. Food and Drug Administration (FDA) authorized IDP-126 (branded as Cabtreo) from Bausch Health. Cabtreo, being the first fixed-dose, triple-combination topical treatment for acne, features a distinctive formulation that targets various acne-inducing elements, providing patients with a robust new therapeutic choice and improving the market options in the region.
The Asia Pacific area is expected to see the fastest growth, with an estimated CAGR of 6.02% between 2024 and 2032. The rise in skincare awareness boosts in disposable income, and the swift growth of the cosmetics sector in countries such as China are fueling market expansion in this area. Japan and South Korea are also important markets, as both nations are experiencing an increase in demand for tailored skincare products. As consumer demands change, firms in the Asia Pacific area are modifying their offerings to address various skin types, establishing the region as an emerging center for acne treatment advancements.
Recent Market Developments
➢May 2024: The Ordinary, recognized for its simple skincare philosophy, introduced the Saccharomyces Ferment 30% Milky Toner. This item, utilizing yeast fermentation technology, aligns with the brand's goal to provide effective skincare through innovative formulations, attracting consumers seeking advanced, science-based solutions for acne.
➢January 2023: AbbVie launched the SkinMedica Even & Correct Collection, a series designed to address hyperpigmentation and dark spots through clinical formulation. This set contains the Advanced Brightening Treatment, Dark Spot Cream, and Brightening Treatment Pads. These items collaborate to balance skin tone and improve complexion, providing specific remedies for those experiencing acne-related hyperpigmentation.
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics
4.1 Market Analysis
4.2 PESTLE Analysis
4.3 Porter's Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Drug Volume: Production and usage volumes of pharmaceuticals.
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients.
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.2 Pricing
6.4 Strategic Initiatives
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Acne Treatment Market Segmentation, by Product
7.1 Chapter Overview
7.2 Therapeutic Treatment
7.3 Devices
8. Acne Treatment Market Segmentation, By Acne Type
8.1 Chapter Overview
8.2 Moderate
8.3 Mild
8.4 Moderate To Severe
9. Acne Treatment Market Segmentation, By Drug Type
9.1 Chapter Overview
9.2 Over the Counter (OTC)
9.3 Prescription
10. Acne Treatment Market Segmentation, By Route of Administration
10.1 Chapter Overview
10.2 Oral
10.3 Topical
10.4 Injectable
11. Acne Treatment Market Segmentation, By Age Group
11.1 Chapter Overview
11.2 10 to 17 Years
11.3 18 to 44 Years
11.4 45 to 64 Years
11.5 65 Years & Above
12. Regional Analysis
13. Company Profiles
14. Use Cases and Best Practices
15. Conclusion
Speak with Our Expert Analyst Today to Gain Deeper Insights @
About Us:
S&S Insider is a global leader in market research and consulting, shaping the future of the industry. Our mission is to empower clients with the insights they need to thrive in dynamic environments. Utilizing advanced methodologies such as surveys, video interviews, and focus groups, we provide up-to-date, accurate market intelligence and consumer insights, ensuring you make confident, informed decisions.
Akash Anand
SNS Insider | Strategy and Stats
+1 415-230-0044
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram
YouTube
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN11112024003118003196ID1108872407